Brief: Bicara Therapeutics Inc QTRLY Loss Per Share $0.39
27/03/2025 11:38
March 27 (Reuters) - Bicara Therapeutics Inc BCAX.O: BICARA THERAPEUTICS INC: QTRLY LOSS PER SHARE $0.39 BICARA THERAPEUTICS INC: CO EXPECTS ITS EXISTING CASH AND CASH EQUIVALENTS WILL FUND OPERATIONS INTO H1 OF 2029 Source text: ID:nGNX20h3Sh Further company coverage: BCAX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bicara Therapeutics
See all newsBrief: Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Bicara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027
Brief: Bicara Therapeutics Announces Appointments Of Jeremy Bender And Christy Oliger To Board Of Directors